Whether developing oral biologics, complex peptides, targeted delivery systems or other novel therapeutic modalities, generating reliable bioanalytical data is essential for making informed development decisions.
Veloxity partnered with Toralgen to provide:
Together, the teams generated the data supporting evaluation of Toralgen’s proprietary oral biologics platform.
Learn how Toralgen and Veloxity collaborated to generate the bioanalytical data supporting evaluation of a novel oral biologics platform.
Toralgen recently announced positive preclinical findings demonstrating successful oral delivery across multiple diabesity peptide classes using its proprietary pUDCA nanoparticle platform. Veloxity Labs partnered throughout the program, providing bioanalytical method development, assay validation, advanced LC-MS/MS analysis and pharmacokinetic expertise to generate the high-quality scientific data supporting platform development, future pharmaceutical partnerships and commercialization opportunities.
Whether your organization is developing:
Veloxity provides specialized bioanalytical expertise that helps innovative companies generate reliable data, reduce development risk and move promising therapies forward with confidence.
Bringing an innovative therapeutic platform to the next development milestone requires more than analytical testing. It requires a scientific partner who understands the complexities of emerging modalities, adapts to evolving program needs and delivers data you can trust.
Veloxity combines deep scientific expertise with responsive collaboration to help clients navigate complex bioanalytical challenges with confidence.
When development timelines are compressed, every day matters. Veloxity’s experienced team, streamlined processes and collaborative approach help clients initiate studies quickly, minimizing delays and keeping critical milestones on track.
Our scientists bring decades of experience supporting pharmaceutical and biotechnology companies across preclinical and clinical development. From study design through data interpretation, we work alongside your team to solve complex analytical challenges and support informed decision-making.
Emerging therapeutic modalities demand specialized analytical approaches. Veloxity has extensive experience supporting complex peptides, biologics, GLP-1 therapeutics and other advanced drug platforms, helping clients overcome the unique challenges these programs present.
Our advanced analytical capabilities enable sensitive, accurate and reliable measurement of complex molecules across a wide range of study types. Combined with scientific expertise, these technologies provide the robust data needed to support critical development decisions.
No two therapeutic platforms are alike. Veloxity develops fit-for-purpose bioanalytical methods tailored to each program, ensuring assays are optimized for your specific molecule, matrix and study objectives while meeting applicable regulatory expectations.
We believe the best outcomes come from collaboration. Clients work directly with experienced scientists who are accessible, proactive and invested in the success of each program. From project kickoff through final reporting, Veloxity serves as an extension of your scientific team.
Whether you need end-to-end bioanalytical support or specialized expertise for a single phase of development, Veloxity adapts to your program’s unique requirements.
Our team works alongside your scientists to provide:
✓ Bioanalytical method development
✓ Assay validation
✓ LC-MS/MS and HRMS analysis
✓ Pharmacokinetic expertise
✓ Scientific consultation
✓ Responsive project support
Let’s discuss how Veloxity can support your next development milestone through specialized bioanalytical expertise.
